Ontario study casts doubt on clinical significance of gadolinium brain deposits
TORONTO, ONTARIO — A new study from the Institute for Clinical Evaluative Sciences (ICES) and Lawson Health Research Institute has cast doubt on the clinical significance of brain deposits of gadolinium (a chemical contrast agent commonly used to enhance MR imaging). In 2015, the US Food and Drug